Patent details

301364 Product Name: sebetralstat of een farmaceutisch aanvaardbaar zout of solvaat daarvan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301364
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3224256
Status:
SPC granted but not yet in force
Application number:
301364
Procedural language:
Dutch
First Applicant Residence Country:
United Kingdom (GB)

Marketing Authorization

Marketing Authorization Number:
EU/1/25/1975
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/09/2025
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
30/01/2026
First Marketing Authorization date:
18/09/2025
Grant date:
30/03/2026
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
30/01/2026
SPC/SPC Extension Expiration Date:
17/09/2040
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
30/01/2026
 
 

 

Name:
Kalvista Pharmaceuticals Limited
Address:
Porton Science Park Bybrook Road, SP4 0BF, Porton DownWiltshire, United Kingdom (GB)

Agent

Name:
ir. B.Ch. Ledeboer c.s
From:
30/01/2026
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

Bulletin Heading:
SPC
Journal edition number:
05/26
Publication date:
04/02/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/11/2035
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
30/03/2026 Outgoing Correspondence Decision grant 1 PDF /1/3/3/8/0/0801208331/docs/301364_8_301364702365l504a.pdf
30/03/2026 Certificate Certificate 1 PDF /1/3/3/8/0/0801208331/docs/301364_9_spcmedcertificate20260330132125916.pdf
02/02/2026 Outgoing Correspondence Confirmation receipt request 2 PDF /1/3/3/8/0/0801208331/docs/301364_7_301364693844l174.pdf
30/01/2026 Application Form First filed application form 3 PDF /1/3/3/8/0/0801208331/docs/301364_0_applicationform20260130042519659.pdf
30/01/2026 SPC Documents Marketing Authorization SPC 3 PDF /1/3/3/8/0/0801208331/docs/301364_1_supplprotectioncertificate20260130042519711.pdf
30/01/2026 SPC Documents Summary of the characteristics of the product 14 PDF /1/3/3/8/0/0801208331/docs/301364_2_supplprotectioncertificate20260130042519720.pdf
30/01/2026 SPC Documents Annex SPC 14 PDF /1/3/3/8/0/0801208331/docs/301364_3_supplprotectioncertificate20260130042519738.pdf
30/01/2026 SPC Documents Annex SPC 2 PDF /1/3/3/8/0/0801208331/docs/301364_4_supplprotectioncertificate20260130042519730.pdf
30/01/2026 SPC Documents Annex SPC 1 PDF /1/3/3/8/0/0801208331/docs/301364_5_supplprotectioncertificate20260130042519746.pdf
30/01/2026 SPC Documents Accompanying letter SPC 2 PDF /1/3/3/8/0/0801208331/docs/301364_6_supplprotectioncertificate20260130042519702.pdf